DVI Closes $454 Million Asset-Backed Securitization; Company Has Placed $5.3 Billion in 32 ABS Transactions.

Business Editors

JAMISON, Pa.--(BUSINESS WIRE)--May 22, 2003

DVI, Inc. (NYSE:DVI) announced the successful completion of a $454 million equipment lease asset-backed securitization.

To date, DVI has completed 32 asset-backed securitizations, and since the initial transaction in 1991, the Company has placed $5.3 billion of such asset-backed notes in the market. The securitized assets in this transaction are comprised of loans and leases secured by medical equipment.

Michael A. O'Hanlon, president and chief executive officer of DVI, said, "We are pleased with the successful completion of this transaction in a capital market that is very important to DVI. Our reception in the ABS market confirms our belief that investors recognize the value of our healthcare assets. This asset-backed securitization market also allows DVI to add significant value for its clients in their effort to acquire the exciting new medical equipment being offered."

This transaction was led by Merrill Lynch & Co. and co-managed by Banc of America Securities LLC, and Nomura Securities International, Inc. Standard & Poor's, Moody's Investor Service, Inc. and Fitch, Inc. rated each of the securitization classes of notes, with 85% of the notes rated AAA or its equivalent and 95% of the notes rated investment grade.

Steven R. Garfinkel, executive vice president and chief financial officer, commented, "We are very pleased with the underwriting syndicate for this transaction and pricing achieved. This is the first DVI transaction rated by all three of the leading rating agencies. We continue our favorable opinion regarding the stability and reliability of the ABS market, which make this type of medium term capital a cornerstone in our financing structure. Our plans include a similar securitization sometime in the Fall 2003."

DVI is an independent specialty finance company for healthcare providers worldwide with $2.8 billion of managed assets. DVI extends loans and leases to finance the purchase of diagnostic imaging and other therapeutic medical equipment directly and through vendor programs throughout the world. DVI also offers lines of credit for working capital backed by healthcare receivables in the United States.

Additional information is available at www.dvi-inc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release, which are not historical facts, are forward-looking statements. Such statements are based upon many important factors, which may be outside the Company's control, causing actual results to differ materially from those suggested.

Such factors include, but are not limited to, legislative and regulatory changes in general, including such changes affecting the healthcare industry, demand for DVI's services, market interest rates, pricing, market condition in the markets in which we operate, the effect of economic conditions, litigation, competition from institutions offering similar products and services, our access to funding on acceptable terms, the ability to complete financing transactions, and other risks identified in the Company's filings with the Securities and Exchange Commission.